New hope for rare blood cancers: first human trial launches
NCT ID NCT05475925
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called DR-01 in adults with rare types of leukemia or lymphoma. The goal is to see if it is safe and can shrink tumors. About 200 people will take part in this early-stage trial.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGGRESSIVE NK CELL LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dren Investigational Site
RECRUITINGBirmingham, Alabama, 35233, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGDuarte, California, 91010, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGIrvine, California, 92612, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGRedwood City, California, 94063, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGNew Haven, Connecticut, 06519, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGTampa, Florida, 33612, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGColumbus, Ohio, 43210, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGCharlottesville, Virginia, 22903, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGFairfax, Virginia, 22031, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGSeattle, Washington, 98109, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGClayton, Victoria, 3168, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGRichmond, Victoria, 3121, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGNedlands, Washington, 6009, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGPierre-Bénite, 69310, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGRennes, 35000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGToulouse, 31059, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGBerlin, 10117, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGCologne, 50937, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGLeipzig, 04103, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGBologna, 40126, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGGoyang-si, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGBarcelona, 08035, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGSalamanca, 37007, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGTainan, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site
RECRUITINGTaipei, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site 1
RECRUITINGNew York, New York, 10021, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site 1
RECRUITINGHong Kong, Hong Kong, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site 1
RECRUITINGBusan, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site 1
RECRUITINGSeoul, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site 2
NOT_YET_RECRUITINGNew York, New York, 10032, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site 2
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site 2
RECRUITINGHong Kong, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site 2
RECRUITINGBusan, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site 2
RECRUITINGSeoul, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dren Investigational Site 3
RECRUITINGSeoul, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a targeted pill boost Chemo's power against a rare blood cancer?
- Promising combo tackles rare blood cancer in chinese patients
- New drug cocktail aims to tackle rare blood cancer
- New drug combo shows promise for rare lymphoma in Real-World study
- New combo shows promise for rare blood cancer
- Massive T-Cell lymphoma database aims to unlock new insights